Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Novel antibacterial agents that inhibit bacterial two-component systems

Oct. 3, 1997

Wakunaga prepares acidic fluoroquinolone

Oct. 3, 1997

Triazole antifungal from Uriach heading for clinic

Oct. 2, 1997

SynPhar selects class C beta-lactamase inhibitor as development candidate

Oct. 2, 1997

T-3811: a new des-F(6)-quinolone from Toyama presented at ICAAC

Oct. 2, 1997

Wakunaga develops new oral fluoroquinolones

Oct. 2, 1997

Nyotran study results described at ICAAC

Oct. 2, 1997

BioChem Therapeutic discovers new anti-HCMV agents

Oct. 2, 1997

New polyene antifungal antibiotic developed at Ajinomoto

Oct. 2, 1997

ABT-606: a new orally active diester prodrug of H2G

Oct. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...